Finally, mutations of IDH1 (IDH1R132) and IDH2 (IDH2R172) leading to production of the TET inhibiting oncometabolite 2-hydroxyglutarate in germ cell cancer cell lines were not detected. Here, IDH1 is linked to malignant germ cell tumor.